marijuana stocks

Form 8-K for VAPOR CORP.


25-Jan-2016

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.On January 22, 2016, Vapor Corp. (“Vapor” or the “Company”) issued a press release announcing that the Units in the July 2015 offering will be separating on January 23, 2016 (with an effective date of January 25, 2016) (the “Separation Date”). On the Separation Date, each Unit will automatically separate into one-fourth of a share of Series A Convertible Preferred Stock and Series A Warrants. Each one-fourth share of Series A Convertible Preferred Stock may be converted into 10 shares of Vapor common stock by the holder by providing written notice to Vapor and its transfer agent by using the Convertible Preferred Stock Conversion Form filed asExhibit 99.1 to this Form 8-K. Holders of Warrants may exercise the Warrants by contacting their broker and sending written notice to the Company. Please use the Warrant Exercise Notification Form filed as Exhibit 99.2 to this Form 8-K (in lieu of the exercise notice attached to the Warrant). All notifications and questions regarding the conversion of the Preferred Stock and exercise of the Warrants should be emailed to excashless@vpco.com.

 

Item 9.01 Financial Statements and Exhibits.99.1 Convertible Preferred Stock Conversion Form

99.2 Warrant Exercise Notification Form

99.3 Press Release dated January 22, 2016

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jushi Holdings Inc. (JUSHF) to Report Fourth Quarter and Full Year 2020 Financial Results on April 29, 2021

Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2020 Financial…

$CANV Closes $6,500,000 Financing With Institutional Investor

CannaVest Closes $6,500,000 Financing With Institutional Investor and Restructures Commitments to Supplier…

$IMLFF Initiates Discovery & Pre-clinical Work on Orofacial Pain

InMed Initiates Discovery & Pre-clinical Work on Orofacial Pain InMed Pharmaceuticals Inc.…

Canopy Growth Corporation (CGC) Reports First Quarter Fiscal 2021 Financial Results

Canopy Growth Reports First Quarter Fiscal 2021 Financial Results Canopy Growth Corporation…